PI-LAB-2024-062

Survodutide, Independent Lab Report

Survodutide 3mg · NextGen Peptides

Discrepancy

Independent testing verdict Discrepancy

This product was authentic but did not match its label.

Identity and purity confirmed; measured content was 91.3% of the label claim.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
98.4%

Label claimed ≥98%

Content accuracy
91.3%

2.74mg measured against 3mg claimed

Test recency
Older result

Published 24 months ago

Specimen PI-LAB-2024-062 Tested by Axiom Mass Spec Services 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 98.4% Meets claim
Identity (MS) Survodutide Confirmed Matches label
Content 3 mg 2.74 mg Within 10% of label

Methodology & chain of custody

Quantitative amino acid analysis against certified reference standard.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Axiom Mass Spec Services. See our full testing methodology.

Lot / batch
D5920-24
Purchased
Analysed
Published
Laboratory
Axiom Mass Spec Services
Test type
Purity & identity

Testing notes

Company was notified before publication and given the standard dispute window.

Original laboratory report: PI-LAB-2024-062-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, Survodutide

Survodutide NextGen Peptides
Purity 98.2% Verified
Survodutide Verity Research Chemicals
Purity 99.4% Verified
Survodutide Apex Peptides
Purity 98.7% Verified